Adverse drug reactions are reported by 30% of Americans. As data emerge regarding the impact of unverified drug allergies, more patients will seek allergy specialists' advice about the verification and management of drug allergies. This course will prepare the general allergist/immunologist to evaluate drug allergy in 2020.

Annual Meeting Attendee - $50
Non-Annual Meeting Attendee - $250

Click here to register


8:00 - 9:00 am

Developing a Beta-Lactam Allergy Evaluation Program with Key Collaborators

Allergy Panelists
Antoine Azar MD FAAAAI
Allison Ramsey, MD FAAAAI
Eric Macy, MD FAAAAI

Infectious Diseases Panelists
Erica Shenoy, MD PhD
Alon Vaisman

Pharmacy Panelists
Mary Staicu, PharmD
Kristin Alvarez, PharmD

9:00  - 10:00 am

Developing Other Drug Allergy Testing Programs

Developing a Chemotherapy and Biologics Desensitization Program
Aleena Banerji, MD FAAAAI
David Hong, MD FAAAAI

Developing an NSAID and Aspirin Challenge Program
Tanya Laidlaw, MD FAAAAI
Rebecca Saff, MD PhD FAAAAI

10:00 - 11:00 am

All About Rashes: A Case-Based Tour of Drug-Induced Eruptions

Robert Micheletti, MD (Severe Cutaneous Adverse Reactions)
Aturoto Saavedra, MD PhD (Vesiculobulous Eruptions)
Misha Rosenbach, MD (Thinking Beyond Drug Eruptions)

11:00 am - 12:00 pm

Hands-On Drug Allergy Testing Workshops

Allena Banerji, MD FAAAAI
Eric Macy, MD FAAAAI
Autumn Guyer, MD FAAAAI
Cosby Stone Jr., MD MPH
Jason Trubiano, MD PhD
Elizabeth Phillips, MD FAAAAI
Rebecca Saff, MD PhD FAAAAI
Paul Bigliardi, MD

12:00 - 1:00 pm

Discussing Practical Differences in Allergy Assessments for Specific Populations

Children Panelists
Ana Dioun Broyles
Moshe Ben-Shoshan, MD FAAAAI

Pregnant Women Panelists
Eric Macy, MD FAAAAI
Anna Wolfson, MD

Multiple Drug Allergy Syndrome Panelists
Melissa Iammatteo, MD
Eric Macy, MD FAAAAI